Benfotiamine Counteracts Smoking-induced Vascular Dysfunction In Healthy Smokers
Effect | Increase |
Trial Design | Double blind |
Trial Length | 1-2 Weeks |
Number of Subjects | 20 |
Sex | Both Genders |
Age Range | 18-29, 30-44 |
Body Types | Average |
The reduction in blood flow associated with acute smoking was halved with a 3-day preload of 1050mg Benfotiamine ,with some protective effects on inflammatory markers (sVCAM) but no alterations in blood pressure or heart rate.